Quinoa is a good source of protein, omega-3s and dietary fiber. The whole grain is also rich in antioxidants, which have been ...

More than 100 million people in the U.S. have some allergy each year. That’s about every 1 in 3 adults. For many, the fix is ...

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid.

The SARS-CoV-2 virus also depends on an enzyme, called Mpro, to replicate in host cells. Because cruzain and Mpro are ...

A study of almost half the population of France has shown that young and middle-aged people who had been vaccinated against COVID-19 with mRNA vaccines have been 74 percent less likely to subsequently ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...